CXL.AXCXL.AXASX
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank25
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P25
Within normal range
vs 2Y Ago
-0.5x
Contraction
Streak
1 qtr
Consecutive growthRecovering
PeriodValue
Q4 2025-10.11%
Q2 2025-36.86%
Q4 2024-4.33%
Q2 202412.29%
Q4 202312.74%
Q2 202363.57%
Q4 202223.46%
Q2 2022-15.08%
Q4 202120.02%
Q2 202159.22%
Q4 2020-18.29%
Q2 202052.14%
Q4 2019-34.49%
Q2 2019-8.31%
Q4 201837.17%
Q2 201829.36%
Q4 2017-46.45%
Q2 201790.10%
Q4 20160.00%
Q2 20160.00%
Q2 20150.00%